Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06894199 · ClinicalTrials.gov registry record
Work2Prevent Plus: Structural Intervention to Promote HIV Care in Black Sexual Minority Men
A clinical trial of HIV, sponsored by University of Chicago.
- Recruiting
- Registry status
- 132
- Enrollment target
- 1
- Study location
NCT06894199 is a study of HIV that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 132 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06894199, a study of HIV, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about the pilot test of the employment program among young Black sexual minority men. The main question it aims to answer is: What is the feasibility and acceptability of the employment program? Young Black sexual minority male participants will attend the two day employment program and will complete four study surveys over the course of 13 months. Employment program facilitators will complete a study survey and participate in a focus group over the course of 1 day.
Conditions Studied
Interventions
- OTHER The Work Shop
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2025-04-22 |
| Est. Completion | 2027-04-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06894199
The ClinicalTrials.gov registry entry for NCT06894199 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (70% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which The Work Shop is the first listed.
NCT06894199 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06894199 about?
NCT06894199 is a clinical study titled "Work2Prevent Plus: Structural Intervention to Promote HIV Care in Black Sexual Minority Men". The goal of this observational study is to learn about the pilot test of the employment program among young Black sexual minority men. The main question it aims to answer is: What is the feasibility and acceptability of the employment program? Young Black sexual minority male participants will att...
What is the current status of trial NCT06894199?
This trial is currently recruiting. The enrollment target is 132 participants. The study started on 2025-04-22. Estimated completion is 2027-04-22.
What conditions does trial NCT06894199 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT06894199?
The interventions under investigation include: The Work Shop (OTHER).
Who is sponsoring clinical trial NCT06894199?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06894199 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transitional Housing and HIV Health
RECRUITING
-
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
RECRUITING · Phase 1
-
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
RECRUITING
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.